The Global High Potent Pharmaceuticals Product Market is projected to reach US$ 452.18 billion by 2031, up from US$ 260.62 billion in 2024, expanding at a CAGR of 8.3% during 2025–2031. Market growth is being supported by the increasing development of targeted therapies, rising demand for oncology treatments, growing adoption of highly potent active pharmaceutical...